Free tool
Drug Trial Radar: Endocrinology and women's health
Last checked: Nov 20, 2026Latest source record: Jul 8, 2026 (registry update on this page)ClinicalTrials.gov last updated: Nov 20, 2026Methods & limitations
Filters
Filters are saved in the page address, so a filtered view can be bookmarked or shared.
Matching drug trials
4
Not yet recruiting, industry sponsors, Endocrinology and women's health, Phase 3
By trial status
The same filters, counted in each status. Pick one to switch.
- Completed328
4 trials
Showing 1 to 4, recently updated first.
- Phase 3 Long Term Safety Extension Study of LUM-201 in Children With Growth Hormone DeficiencyPivotal-lookingNot yet recruiting
Lumos PharmaIndustry
NCT07129759 · 150 participants (planned) · Start Feb 2027 · Primary completion Feb 2030
Drug: LUM-201 · For: Growth Hormone Deficiency (GHD)
- A Phase III Clinical Trial to Evaluate the Efficacy and Safety of Octreotide Long-acting Injection in Patients With AcromegalyPivotal-lookingNot yet recruiting
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.Industry
NCT07623824 · 154 participants (planned) · Start May 31, 2026 · Primary completion Jul 31, 2029
Drug: SYHX2008; Sandostatin LAR® · For: Diagnosed With Acromegaly, Currently in the Active Stage of the Disease
- A Clinical Study Comparing Ankle Swelling Caused by Two Different Blood Pressure Medications, Levamlodipine and Amlodipine, in Post-menopausal Women With Mild High Blood Pressure.Pivotal-lookingNot yet recruiting
Zentiva, k.s.Industry
NCT07618806 · 344 participants (planned) · Start Nov 30, 2026 · Primary completion Dec 31, 2027
Drug: Amlodipine · For: Hypertension; Oedema
- To Evaluate the Efficacy and Safety of Abaloparatide Injection (QLG2128) in the Treatment of Postmenopausal Women With Osteoporosis and at High Risk of FracturePivotal-lookingNot yet recruiting
Qilu Pharmaceutical Co., Ltd.Industry
NCT06898060 · 282 participants (planned) · Start Jun 2025 · Primary completion May 2027
Drug: QLG2128; Teriparatide Injection · For: Postmenopausal Women With Osteoporosis
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.